Mexico Real World Evidence Solutions Market Size & Outlook
Mexico real world evidence solutions market, 2018-2030 (US$M)
Related Markets
Mexico real world evidence solutions market highlights
- The Mexico real world evidence solutions market generated a revenue of USD 18.7 million in 2023 and is expected to reach USD 35.6 million by 2030.
- The Mexico market is expected to grow at a CAGR of 9.7% from 2024 to 2030.
- In terms of segment, services was the largest revenue generating component in 2023.
- Services is the most lucrative component segment registering the fastest growth during the forecast period.
Real world evidence solutions market data book summary
| Market revenue in 2023 | USD 18.7 million |
| Market revenue in 2030 | USD 35.6 million |
| Growth rate | 9.7% (CAGR from 2023 to 2030) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Data Sets |
| Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Other key industry trends
- In terms of revenue, Mexico accounted for 0.7% of the global real world evidence solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil real world evidence solutions market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 35.6 million by 2030.
Services was the largest segment with a revenue share of 57.75% in 2023. Horizon Databook has segmented the Mexico real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
The data on real-world efficacy and safety may affect reimbursement & utilization of novel but relatively expensive pharmaceuticals or medical devices, making RWE research more vital than ever. The Translation of Clinical Data to Real World was conducted according to data released by the Department of Oncology, University of Ulsan College of Medicine, and Asan Medical Center.
However, implementing change in the actual world goes beyond demonstrating efficacy. Healthcare systems of some countries are responsive, while others need numerous stages to integrate novel therapies into routine practice. Mexico's unique healthcare system has many complexities that influence access to oncologic care.
The RWD availability in Mexico is limited. Patient-level data is mainly sourced from national health datasets, such as mortality data, the health and nutrition survey, and public hospital administrative data. However, these datasets need more connectivity between them.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Real World Evidence Solutions Market Scope
Real World Evidence Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico real world evidence solutions market size, by component, 2018-2030 (US$M)
Mexico Real World Evidence Solutions Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
